Photocure ASA is a Norwegian pharmaceutical company founded in 1993 and listed on Oslo Stock Exchange. The company develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology, targeting key dermatology and oncology markets.
Photocure has one product with sales and marketing approval:
- Hexvix, for the detection of bladder cancer.
Photocure has its headquarters in Oslo, Norway. The company uses to a large extent external suppliers for functions such as production, R&D, and regulatory matters. Photocure profits from a strong academic network as well as skilled and experienced development staff in-house.
If you are a media representative and you cannot find the information you need on this web site, please feel free to contact us.
Subscribe to news and stock exchange notices from Photocure.